Abstract：Objective To evaluate the clinical effectiveness of integrated management during the perinatal period for fetuses diagnosed with total anomalous pulmonary venous connection (TAPVC) by prenatal echocardiography. Methods Clinical data of 64 cases of TAPVC fetuses diagnosed by prenatal echocardiography and managed with integrated perinatal care in Qingdao Women and Children's Hospital from January 2017 to December 2021 were retrospectively analyzed. Integrated perinatal care included multidisciplinary collaboration among obstetrics, fetal medicine, ultrasound, pediatric cardiology, pediatric anesthesia, and neonatology. Results Among the 64 TAPVC fetuses, there were 29 cases of supracardiac type, 27 cases of intracardiac type, 2 cases of infracardiac type, and 6 cases of mixed type. Chromosomal analysis was performed in 42 cases, and no obvious abnormalities were found. Among the 64 TAPVC fetuses, 37 were induced labor, and 27 were followed up until term birth. Among the 27 TAPVC cases, 2 cases accepted palliative care, 2 cases were referred to another hospital for treatment and lost to follow-up, while the remaining 23 cases underwent primary repair surgery. One case died within 6 months after the operation due to low cardiac output syndrome, while the other 22 cases were followed up for (2.1±0.3) years with good outcomes (2 cases underwent a second surgery within 1 year after the first operation due to anastomotic stenosis or pulmonary vein stenosis). Conclusions TAPVC fetuses can achieve good outcomes with integrated management during the perinatal period.
SUN Yi,PAN Si-Lin,JI Zhi-Xian et al. Integrated management during the perinatal period for total anomalous pulmonary venous connection[J]. CJCP, 2023, 25(5): 502-507.
Yoshimura N, Fukahara K, Yamashita A, et al. Current topics in surgery for isolated total anomalous pulmonary venous connection[J]. Surg Today, 2014, 44(12): 2221-2226. PMID: 24633930. DOI: 10.1007/s00595-014-0877-5.
Souka AP, von Kaisenberg CS, Hyett JA, et al. Increased nuchal translucency with normal karyotype[J]. Am J Obstet Gynecol, 2005, 192(4): 1005-1021. PMID: 15846173. DOI: 10.1016/j.ajog.2004.12.093.
Bilardo CM, Müller MA, Pajkrt E, et al. Increased nuchal translucency thickness and normal karyotype: time for parental reassurance[J]. Ultrasound Obstet Gynecol, 2007, 30(1): 11-18. PMID: 17559183. DOI: 10.1002/uog.4044.
Zhang X, Sun Y, Zhu J, et al. Epidemiology, prenatal diagnosis, and neonatal outcomes of congenital heart defects in eastern China: a hospital-based multicenter study[J]. BMC Pediatr, 2020, 20(1): 416. PMID: 32878605. PMCID: PMC7466801. DOI: 10.1186/s12887-020-02313-4.
Gupta N, Leven L, Stewart M, et al. Transport of infants with congenital heart disease: benefits of antenatal diagnosis[J]. Eur J Pediatr, 2014, 173(5): 655-660. PMID: 24326382. DOI: 10.1007/s00431-013-2231-0.
Yang L, He X, Lu Y, et al. Integrated model for the prenatal diagnosis and postnatal surgical treatment of total anomalous pulmonary venous connection: a multidisciplinary collaborative experience and preliminary results[J]. J Card Surg, 2019, 34(11): 1264-1272. PMID: 31475761. DOI: 10.1111/jocs.14242.
Holland BJ, Myers JA, Woods CR. Prenatal diagnosis of critical congenital heart disease reduces risk of death from cardiovascular compromise prior to planned neonatal cardiac surgery: a meta-analysis[J]. Ultrasound Obstet Gynecol, 2015, 45(6): 631-638. PMID: 25904437. DOI: 10.1002/uog.14882.
Shi G, Zhu Z, Chen J, et al. Total anomalous pulmonary venous connection: the current management strategies in a pediatric cohort of 768 patients[J]. Circulation, 2017, 135(1): 48-58. PMID: 27881562. DOI: 10.1161/CIRCULATIONAHA.116.023889.
Shaw FR, Chen JM. Surgical considerations in total anomalous pulmonary venous connection[J]. Semin Cardiothorac Vasc Anesth, 2017, 21(2): 132-137. PMID: 28107801. DOI: 10.1177/1089253216688535.
